We next verified whether the MTE‐mediated inhibition of glioma cells was acted by blocking the Wnt/β‐catenin pathway, decreasing miR‐542‐3p expression and elevating SFRP1 expression. The gene discussed is SFRP1; the disease is central nervous system cancer.